Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics. Its pipeline consists of COR388, COR588, COR788, COR822, and Coronavirus 3CL protease inhibitor. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Thye Dirk | CHIEF EXECUTIVE OFFICER | Jan 16 '24 | Option Exercise | 0.79 | 240,530 | 190,791 | 689,441 | Jan 17 04:48 PM | Lamond David | Director | Dec 14 '23 | Buy | 1.04 | 22,627 | 23,532 | 2,347,545 | Dec 14 06:21 PM | Lamond David | Director | Dec 13 '23 | Buy | 1.00 | 22,627 | 22,627 | 2,324,918 | Dec 14 06:21 PM | Lamond David | Director | Dec 12 '23 | Buy | 1.02 | 22,327 | 22,774 | 2,302,291 | Dec 14 06:21 PM | Lamond David | Director | Dec 12 '23 | Buy | 1.00 | 300 | 300 | 2,279,964 | Dec 14 06:21 PM | Lamond David | Director | Dec 07 '23 | Buy | 1.01 | 19,123 | 19,314 | 2,279,664 | Dec 07 06:30 PM | Lamond David | Director | Dec 06 '23 | Buy | 1.02 | 19,123 | 19,505 | 2,260,541 | Dec 07 06:30 PM | Lamond David | Director | Dec 05 '23 | Buy | 1.01 | 19,123 | 19,314 | 2,241,418 | Dec 07 06:30 PM | Lamond David | Director | Dec 01 '23 | Buy | 0.94 | 14,378 | 13,515 | 2,222,295 | Dec 01 01:38 PM | Lamond David | Director | Nov 30 '23 | Buy | 0.90 | 14,378 | 12,940 | 2,207,917 | Dec 01 01:38 PM | Lamond David | Director | Nov 29 '23 | Buy | 0.98 | 14,378 | 14,090 | 2,193,539 | Dec 01 01:38 PM | Lamond David | Director | Aug 31 '23 | Buy | 1.32 | 41,026 | 54,154 | 2,179,161 | Aug 31 06:42 PM | Lamond David | Director | Aug 30 '23 | Buy | 1.31 | 41,026 | 53,744 | 2,138,135 | Aug 31 06:42 PM | Lamond David | Director | Aug 17 '23 | Buy | 1.29 | 24,766 | 31,948 | 2,097,109 | Aug 17 06:08 PM | Lamond David | Director | Aug 16 '23 | Buy | 1.29 | 117,348 | 151,379 | 2,072,343 | Aug 17 06:08 PM | Lamond David | Director | Aug 15 '23 | Buy | 1.32 | 107,886 | 142,410 | 1,954,995 | Aug 17 06:08 PM | Thye Dirk | Chief Executive Officer | Aug 10 '23 | Buy | 1.26 | 88,000 | 110,880 | 448,911 | Aug 11 04:15 PM | Thye Dirk | Chief Executive Officer | Aug 08 '23 | Buy | 1.24 | 80,000 | 99,200 | 360,911 | Aug 09 06:23 PM | Hannah Brendan | Chief Business Officer | Aug 08 '23 | Buy | 1.22 | 71,762 | 87,550 | 201,555 | Aug 09 06:21 PM | McLoughlin Margaret | Director | Aug 08 '23 | Buy | 1.23 | 8,000 | 9,840 | 8,000 | Aug 09 06:18 PM |
|